ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
Dow Jones
38.686,32
1,51%
Euro vs US Dollar
1,08565
0,00%
Bitcoin
67.455,79
-0,36%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Ocean Biomedical Inc (OCEAW)

  7. Ocean Biomedical Inc (OCEAW) News

OCEAW

Ocean Biomedical (OCEAW)

Ocean Biomedical Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:OCEAW
DatumZeitQuelleÜberschriftSymbolFirma
30/05/202415h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCEAWOcean Biomedical Inc
14/05/202421h10Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:OCEAWOcean Biomedical Inc
25/05/202314h01GlobeNewswire Inc.Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Addition to the Russell 2000® IndexNASDAQ:OCEAWOcean Biomedical Inc
23/05/202314h01GlobeNewswire Inc.Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Award for Novel Cancer Immunotherapy Treatment, Granted for Prostate Cancer, Colon Cancer, Ovarian Cancer, Kidney Cancer, Breast Cancer, Glioblastoma, Melanoma, and Lung Cancer.NASDAQ:OCEAWOcean Biomedical Inc
16/05/202314h01GlobeNewswire Inc.Ocean Biomedical, Inc. Enters into a $25 Million Convertible Note FacilityNASDAQ:OCEAWOcean Biomedical Inc
01/05/202314h01GlobeNewswire Inc.Ocean Biomedical (NASDAQ: OCEA) Announces 70% Increase in Price Target by EF Hutton from $10 to $17 on New Glioblastoma Results Validating Profound Tumor Suppression with Anti-Chi3L1 AntibodyNASDAQ:OCEAWOcean Biomedical Inc
27/04/202314h01GlobeNewswire Inc.Ocean Biomedical (NASDAQ: OCEA) Announces New Glioblastoma Results Validating Profound Tumor Suppression with Anti-Chi3L1 AntibodyNASDAQ:OCEAWOcean Biomedical Inc
25/04/202314h01GlobeNewswire Inc.Ocean Biomedical (NASDAQ: OCEA) on World Malaria Day Announces Sharing of New Malaria Vaccine Paradigm at PATH Malaria Research Retreat in Washington, DC, by Scientific Co-founder Dr. Jonathan KurtisNASDAQ:OCEAWOcean Biomedical Inc
20/04/202314h01GlobeNewswire Inc.Ocean Biomedical (NASDAQ: OCEA) Announces Notice of Allowance for U.S. Patent Application for Breakthrough Pulmonary Fibrosis Treatments Issued to Scientific Co-founder Dr. Jack A. Elias.NASDAQ:OCEAWOcean Biomedical Inc
17/04/202314h01GlobeNewswire Inc.$134 Million in Financial Backing for Innovative Research and IND Fillings Announced by Ocean Biomedical (NASDAQ: OCEA); Provides Latest Updates on Advancement of Platform, Novel Discoveries in Malaria, Pulmonary Fibrosis and OncologyNASDAQ:OCEAWOcean Biomedical Inc
13/04/202314h01GlobeNewswire Inc.Ocean Biomedical (NASDAQ: OCEA) Announces Notice of Allowance for U.S. Patent Application for Developing “Whole New Class” of Malaria Therapeutics Issued to Scientific Co-founder Dr. Jonathan KurtisNASDAQ:OCEAWOcean Biomedical Inc
06/04/202314h01GlobeNewswire Inc.Ocean Biomedical (NASDAQ: OCEA) Will Target Pulmonary Fibrosis Discoveries as Novel Treatments of Hermansky-Pudlak SyndromeNASDAQ:OCEAWOcean Biomedical Inc
21/03/202313h01GlobeNewswire Inc.Ocean Biomedical (NASDAQ: OCEA) Details Novel Malaria Therapeutic Discoveries at the NIH Laboratory of Malaria Vaccinology and Immunology on PfGARP’s Potential as a Highly Effective Vaccine Target and Therapeutic Candidate to Treat MalariaNASDAQ:OCEAWOcean Biomedical Inc
16/03/202313h01GlobeNewswire Inc.Ocean Biomedical (NASDAQ: OCEA) Announces Initiation of Equity Analyst Coverage by Fundamental Research Corp. with a “Buy” RecommendationNASDAQ:OCEAWOcean Biomedical Inc
14/03/202313h01GlobeNewswire Inc.Ocean Biomedical (NASDAQ: OCEA) Announces Initiation of Equity Analyst Coverage by EF Hutton with a “Buy” RecommendationNASDAQ:OCEAWOcean Biomedical Inc
09/03/202314h01GlobeNewswire Inc.Ocean Biomedical (NASDAQ: OCEA) Shares Detailed Research Data on Anti-Tumor Pathway Discoveries and Their Potential for Treatment of Non-Small Cell Lung Cancer, Metastatic Melanoma, and Glioblastoma by Scientific Co-founderNASDAQ:OCEAWOcean Biomedical Inc
28/02/202314h01GlobeNewswire Inc.Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Award of New Patent to Scientific Co-Founder Dr. Jake Kurtis for Novel Malaria Vaccine TargetNASDAQ:OCEAWOcean Biomedical Inc
23/02/202314h01GlobeNewswire Inc.Ocean Biomedical (NASDAQ: OCEA) Celebrates Discovery of Bispecific Antibodies and Immune Checkpoint Inhibitors That Kill Glioblastoma Cells and Melanoma Cells, and Block the Metastasis of Malignant Melanoma Cells to the Lung by Over 90%NASDAQ:OCEAWOcean Biomedical Inc
16/02/202314h01GlobeNewswire Inc.Ocean Biomedical to Ring The Nasdaq Stock Market Opening BellNASDAQ:OCEAWOcean Biomedical Inc
15/02/202314h01GlobeNewswire Inc.Ocean Biomedical Debuts as Publicly Traded Company Focused on Accelerating the Commercialization of Innovative Assets from Research Universities and Medical CentersNASDAQ:OCEAWOcean Biomedical Inc
09/02/202315h15GlobeNewswire Inc.Ocean Biomedical and Aesther Healthcare Acquisition Corp. Announce the Award of New Patents for Novel Monospecific and Bispecific Antibodies that Suppress Multiple Cancer TypesNASDAQ:OCEAWOcean Biomedical Inc
30/01/202315h15GlobeNewswire Inc.Ocean Biomedical and Aesther Healthcare Acquisition Corp. Announce Publication of Discovery Data for a Major Anti-Tumor Pathway in Malignant Melanoma and Other CancersNASDAQ:OCEAWOcean Biomedical Inc
24/01/202315h15GlobeNewswire Inc.Ocean Biomedical Provides Corporate Update and Company SummaryNASDAQ:OCEAWOcean Biomedical Inc
05/10/202213h45GlobeNewswire Inc.Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) and Ocean Biomedical, Inc. Announce Execution of a Second up to $40 Million Backstop Agreement, for a Total of up to $80 MillionNASDAQ:OCEAWOcean Biomedical Inc
31/08/202213h47GlobeNewswire Inc.Aesther Healthcare Acquisition Corp. Has Entered Into an Agreement and Plan of Merger with Ocean Biomedical, Inc., a Next-Generation Biopharma Company, to List on NASDAQNASDAQ:OCEAWOcean Biomedical Inc
 Showing the most relevant articles for your search:NASDAQ:OCEAW

Kürzlich von Ihnen besucht

DBI
TDXP
Tec DAX
NYSE
MRK
Merck
USOTC
BASFY
BASF (QX)
PM
XAUUSD
Gold vs US Dollar
FX
EURUSD
Euro vs US Dollar
USOTC
RHHBY
Roche (QX)
NASDAQ
TSLA
Tesla
DBI
MDAX
MDAX
NYSE
KO
Coca Cola
CCOM
US100
US Tech 100
CCOM
US500
US 500
TG
BAYN
Bayer
CCOM
SILVER
SILVER
DBI
DAX
DAX
USOTC
ADDYY
Adidas (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten